Cargando…

Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer

The present study aimed to investigate the effects of excision repair cross-complementation 1 (ERCC1) expression on the prognosis of patients with non-small cell lung cancer (NSCLC). A total of 140 patients with NSCLC who underwent radical resection were included. Immunohistochemical staining was pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Dan, Ma, Xiaomei, Wu, Zhenhua, Wang, Yang, Zhao, Shuyuan, Han, Feng, Sun, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588058/ https://www.ncbi.nlm.nih.gov/pubmed/28927101 http://dx.doi.org/10.3892/ol.2017.6649

Ejemplares similares

p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair
por: Wang, Qi-En, et al.
Publicado: (2013)

X-Ray Repair Cross Complementing Protein 1 in Base Excision Repair
por: Hanssen-Bauer, Audun, et al.
Publicado: (2012)

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer
por: Aiello, Marco Maria, et al.
Publicado: (2020)

Complementation of aprataxin deficiency by base excision repair enzymes
por: Çağlayan, Melike, et al.
Publicado: (2015)

Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer
por: Luo, Shan-Shan, et al.
Publicado: (2018)

Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer
por: Fan, Yongfei, et al.
Publicado: (2021)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
por: Mountzios, Giannis, et al.
Publicado: (2008)

The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients
por: Chitapanarux, Imjai, et al.
Publicado: (2020)

Dioscin facilitates ROS-induced apoptosis via the p38-MAPK/HSP27-mediated pathways in lung squamous cell carcinoma
por: Yao, Yinan, et al.
Publicado: (2020)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

Complementation of aprataxin deficiency by base excision repair enzymes in mitochondrial extracts
por: Çağlayan, Melike, et al.
Publicado: (2017)

TIRAP-mediated activation of p38 MAPK in inflammatory signaling
por: Rajpoot, Sajjan, et al.
Publicado: (2022)

Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk
por: Tsai, Chia-Wen, et al.
Publicado: (2018)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
por: Peng, Haiying, et al.
Publicado: (2018)

Cyclophilin A promotes non‐small cell lung cancer metastasis via p38 MAPK
por: Guo, Yinan, et al.
Publicado: (2017)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
por: Hubner, Richard A., et al.
Publicado: (2011)

Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
por: Li, Mu-Xing, et al.
Publicado: (2016)

Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
por: SONG, PENG, et al.
Publicado: (2015)

Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
por: Zhang, Hongming, et al.
Publicado: (2019)

Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer
por: Fang, Yan, et al.
Publicado: (2017)

p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair
por: Mak, Victor CY, et al.
Publicado: (2021)

p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy
por: Escós, Alejandra, et al.
Publicado: (2016)

The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis
por: Yang, Yanlong, et al.
Publicado: (2014)

New Insights into the p38γ and p38δ MAPK Pathways
por: Risco, Ana, et al.
Publicado: (2012)

Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer
por: Li, Wei, et al.
Publicado: (2015)

p38 MAPK Signaling in Osteoblast Differentiation
por: Rodríguez-Carballo, Eddie, et al.
Publicado: (2016)

p38 MAPK in cardioprotection – are we there yet?
por: Martin, E D, et al.
Publicado: (2015)

P38 MAPK and Radiotherapy: Foes or Friends?
por: García-Flores, Natalia, et al.
Publicado: (2023)

Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics
por: Xie, Deyao, et al.
Publicado: (2016)

AB153. Down-regulated expression of excision of repair cross-complementing gene 1 reduces resistance to hydroxycamptothecine in bladder cancer
por: Liu, Yili
Publicado: (2016)

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A
por: Wang, Xiaozhu, et al.
Publicado: (2017)

Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence
por: Wang, Yen-Yun, et al.
Publicado: (2021)

Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2021)

High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis
por: Liu, Qilong, et al.
Publicado: (2018)

ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis
por: Xu, Mei, et al.
Publicado: (2016)

ZCCHC14 regulates proliferation and invasion of non–small cell lung cancer through the MAPK‐P38 signalling pathway
por: Shi, Xiuying, et al.
Publicado: (2020)

p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis
por: Brichkina, Anna, et al.
Publicado: (2016)

Dexamethasone and p38 MAPK inhibition of cytokine production from human lung fibroblasts
por: Higham, Andrew, et al.
Publicado: (2020)

Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFα release
por: Li, Yi-Ping, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_po4uhe18jafe3841ajlq4dns86